As recently as the onset of COVID-19 four years ago, you probably didn’t know what a glucagon-like peptide 1 agonist,...
Pharmaceutical Industry
Yet despite the ubiquitousness of injectable drugs indicated for people with obesity—such as Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—most...
AstraZeneca Plc has explored an acquisition of Bristol Myers Squibb Co., in a megadeal that would create one of the...
For decades, pharmaceutical advertising largely revolved around television commercials urging patients to ask their doctors about branded medication. Increasingly, however,...
Patrick Swayze, Alex Trebek, and Ruth Bader Ginsburg all died of pancreatic cancer. They were wealthy enough to afford any...
A consumer tech VC confessed to me over breakfast that he was injecting himself with an experimental peptide protocol. His...
Insilico Medicine, the Hong Kong-listed AI drug discovery company, has signed a partnership with Korea’s SK Biopharmaceuticals to help develop...
On Thursday morning in New York City, Dr. Shiv Rao stood before a room of health system executives and made...
Novo Nordisk A/S Chief Executive Officer Mike Doustdar says the company’s blockbuster obesity drugs could ultimately pull it into increasingly...
Apoha, a deep tech startup that is building AI models for creating new kinds of substances—from proteins to food products...
In the early days of the generative artificial intelligence boom, Sanofi’s chief digital officer, Emmanuel Frenehard, wasn’t particularly impressed with...
A trio of former Palantir executives who helped spearhead that company’s Life Sciences practice have founded a startup called Perceptic...
For Johanna Mercier, Gilead Sciences’ chief commercial and corporate affairs officer, leadership starts with a clear accounting of what sustains...